Introduction Cervical cancer screening is used to find changes in the cells of the cervix that could lead to cancer. Despite, screening is one of the secondary preventive strategies, the case is still growing. Therefore, the study aimed to assess the uptake of cervical cancer screening services and associated factors among Women living with human immunodeficiency virus at public health Facility in Waliso Town, Ethiopia, 2024. Methods and materials: A facility- based cross=sectional study done among 396 women was conducted from April 1-June 25, 2024 Systematic random sampling was used to select women for face-to-face interviews. The bivariable and multivariable logistic regression analyses were done. The data were collected through the face-to-face interview by a structured questionnaire. For analysis, the data were entered into Epi data version 4.6 and exported to Statistical Package for the Social Sciences version 26 software. Bivariate analysis for candidate variables selection (p 0.25) was used. Multivariable analysis for p-value 0.05 and 95% confidence level were considered as significantly associated. Results: The proportion of cervical cancer screening uptake among HIV-positive women was 12.1%, 95% confidence interval of 9%- 15%. Variables like an age between 40-49 years AOR = 3.65; 95%CI=1.20, 11.07, having college above educational level AOR = 3.04; 95% CI: 1.05, 8.80, Urban residents AOR = 3.49; 95%CI=1.64, 7.44, and having good knowledge AOR 3.9; 95%CI: 1.70, 8.83 were significantly associated with uptake of cervical cancer screening service. Service interruption, poor awareness, and rumor were barrier of uptake of cervical cancer screening among HIV-positive women. Conclusion and recommendation: The finding of this study showed that only one in ten HIV-positive women was screened. We recommend that increasing women’s knowledge about cervical cancer screening, particularly targeting the younger ones, is crucial to enhance the uptake of screening and promote health education among rural women so that recommended cervical cancer screening can be utilized more effectively.
Chuko et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: